MedKoo Cat#: 414582 | Name: ONO-2921

Description:

WARNING: This product is for research use only, not for human or veterinary use.

ONO-2921 is a Novel N-Type Ca Channel Blocker

Chemical Structure

ONO-2921
ONO-2921
CAS#253306-39-7

Theoretical Analysis

MedKoo Cat#: 414582

Name: ONO-2921

CAS#: 253306-39-7

Chemical Formula: C31H48N4O4S2

Exact Mass: 604.3117

Molecular Weight: 604.87

Elemental Analysis: C, 61.56; H, 8.00; N, 9.26; O, 10.58; S, 10.60

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
ONO-2921; ONO2921; ONO 2921
IUPAC/Chemical Name
3-Thiazolidinecarboxylic acid, 4-((((1R)-1-(((cyclohexylmethyl)thio)methyl)-2-oxo-2-((1-(phenylmethyl)-4-piperidinyl)amino)ethyl)amino)carbonyl)-, 1,1-dimethylethyl ester, (4R)-
InChi Key
KCVLHOGZZRHCEW-SVBPBHIXSA-N
InChi Code
InChI=1S/C31H48N4O4S2/c1-31(2,3)39-30(38)35-22-41-21-27(35)29(37)33-26(20-40-19-24-12-8-5-9-13-24)28(36)32-25-14-16-34(17-15-25)18-23-10-6-4-7-11-23/h4,6-7,10-11,24-27H,5,8-9,12-22H2,1-3H3,(H,32,36)(H,33,37)/t26-,27-/m0/s1
SMILES Code
O=C(N1CSC[C@H]1C(N[C@@H](CSCC2CCCCC2)C(NC3CCN(CC4=CC=CC=C4)CC3)=O)=O)OC(C)(C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 604.87 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Miyazaki Y, Sugihara H, Nishiura A, Kadota K, Tozuka Y, Takeuchi H. Appropriate selection of an aggregation inhibitor of fine particles used for inhalation prepared by emulsion solvent diffusion. Drug Dev Ind Pharm. 2017 Jan;43(1):30-41. doi: 10.1080/03639045.2016.1201099. Epub 2016 Jul 12. PMID: 27297256. 2: Ozeki T, Kano Y, Takahashi N, Tagami T, Okada H. Improved bioavailability of a water-insoluble drug by inhalation of drug-containing maltosyl-β-cyclodextrin microspheres using a four-fluid nozzle spray drier. AAPS PharmSciTech. 2012 Dec;13(4):1130-7. doi: 10.1208/s12249-012-9826-z. Epub 2012 Sep 1. PMID: 22945234; PMCID: PMC3513433.